Review: The management of the elderly with hypertension

Ramsay LE , Williams B. , Johnston GD et al. British Hypertension Society guideline for hypertension management 1999: summary. BMJ 1999;319:630-5.

Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-83.

Fletcher AE , Bradley IC , Broxton JS et al. Survival of hypertensive subjects identified on screening: results for sustained and unsustained diastolic hypertension.EurHeart 1992;13:1595-601.

Staessen JA , Fagard R. , Thijs L. et al., for the SYST-EUR trial investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.

Fagard RH , Staessen JA , Thijs L. et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Response to Antihypertensive Therapy in Older Patients with Sustained and Nonsustained Systolic Hypertension. Circulation 2000; 102:1139-44.

SHEP Co-operative Research Group. Prevention of Stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265: 3255-64.

Amery A. , Birkenhäger W. , Brixko P. et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly. Lancet 1985;I:1349-54.

Hansson L. , Zanchetti A. , Carruthers SG et al., for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.

Kaplan N. J-curve not burned off by HOT study. Lancet 1998;351:1748-9.

Somes GW , Pahor M. , Shorr RI , Cusham WC , Applegate WB The role of diastolic blood pressure when treating isolated systolic hypertension .Arch Intern Med 1999;159:2004-9.

Fletcher AE , Bulpitt CJ How far should blood pressure be lowered? New Engl J Med 1992;326:251-54.

Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291:97-104.

MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992 ;304:405-12.

Messerli FH , Grossman E. , Goldbourt U. Are β-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review . JAMA 1998;279:1903-7.

Psaty BM , Smith NL , Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta analysis. JAMA 1997; 277:739-45.

Hansson L. , Lindholm LH , Ekbom T. et al., for the STOP-Hypertension-2 Study group. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity - the Swedish Trial in Old Patients with Hypertension - 2 study. Lancet 1999;354:1751-56.

Davis BR , Cutler JA , Gordon DJ et al. Rationale and design for the Antihypertensive and Lipid LoweringTreatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens 1996;9:342-60.

Lim PO , Donan PT , MacDonald TM Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial.Anglo-Scandinavian Cardiac Outcome Trial. J Hum Hypertens 2000;14:75-8.

Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone: the antihypertensve and lipid-lowering treatment to prevent heart attack trial (ALLHAT).ALLHAT Collaborative Research Group . JAMA 2000; 283:1967-75.

Grimm RH Jr , Margolis KL , Papademetriou V. et al. Baseline characteristics of Participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2001;37:19-37.

Curb JD , Pressel SL , Cutler JA et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276:1886-92.

Tuomilehto J. , Rastentyte D. , Birkenhäger W. et al. Effect of calcium-channel blockade in older patients with diabetes and systolic hypertension. New Engl J Med 1999;340:677-84.

Fletcher AE , Bulpitt CJ Epidemiological aspects of cardiovascular disease in the elderly. J Hypertens 1992;10:S51-S58.

Bulpitt CJ , Fletcher AE , Amery A. et al. The Hypertension in the Very ElderlyTrial (Hyvet): Rationale, methodology and comparison with previous trials. Drugs Aging 1994;5:171-83.

Gueyffier F. , Bulpitt CJ , Boissel JP et al., for the INDANA Group. Antihypertensive drugs in the very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 1999; 353:793-96.

Bulpitt CJ , Fletcher A. , Beckett N. et al. The Hypertension in the Very Elderly Trial (HYVET): Protocol for the main trial. Drugs Aging 2001; (in press).